Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
SCA Pharmaceuticals, Inc.

SCA Pharmaceuticals, Inc. Recalls

All product recalls associated with SCA Pharmaceuticals, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

166

Past Year

Class I (Serious)

Most Recent

Nov 2023

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 81–100 of 166 recalls

Furosemide Injection (SCA Pharmaceuticals) – Precipitate Presence (2018)

Presence of Precipitate: Customer complaint for visible precipitate in product believed to be the active ingredient furosemide.

Class IHigh

FDAAug 27, 2018CT, IN, VA +1 more• SCA Pharmaceuticals, Inc.

Buffered Lidocaine Injection (SCA Pharmaceuticals) – subpotent drug (2018)

Subpotent Drug: Stability data does not support the current expiration dating of 55 days after compounding.

Class IIModerate

FDAJun 29, 2018Nationwide• SCA Pharmaceuticals

Norepinephrine Bitartrate 16mg (SCA) – Sterility Concern (2018)

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

1...3 456 7...9

Page 5 of 9Next

Class II

Moderate

FDAJun 14, 2018Nationwide• SCA Pharmaceuticals, LLC

Fentanyl Citrate Solution (SCA) – Sterility Concern (2018)

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Class IIModerate

FDAJun 14, 2018Nationwide• SCA Pharmaceuticals, LLC

Morphine Sulfate Solution (SCA) – Sterility Concern (2018)

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Class IIModerate

FDAJun 14, 2018Nationwide• SCA Pharmaceuticals, LLC

Fentanyl Bupivacaine (SCA Pharmaceuticals) – sterility risk (2018)

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Class IIModerate

FDAJun 14, 2018Nationwide• SCA Pharmaceuticals, LLC

Phenylephrine HCL 80mg (SCA) – Sterility Concern (2018)

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Class IIModerate

FDAJun 14, 2018Nationwide• SCA Pharmaceuticals, LLC

Norepinephrine Bitartrate 4mg (SCA) – Sterility Concern (2018)

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Class IIModerate

FDAJun 14, 2018Nationwide• SCA Pharmaceuticals, LLC

Phenylephrine HCL 50mg (SCA) – Sterility Concern (2018)

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Class IIModerate

FDAJun 14, 2018Nationwide• SCA Pharmaceuticals, LLC

Norepinephrine Bitartrate 8mg (SCA) – Sterility Concern (2018)

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Class IIModerate

FDAJun 14, 2018Nationwide• SCA Pharmaceuticals, LLC

Phenylephrine Solution (SCA Pharmaceuticals) – sterility risk (2018)

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Class IIModerate

FDAJun 14, 2018Nationwide• SCA Pharmaceuticals, LLC

Phenylephrine HCL 20mg (SCA) – Sterility Concern (2018)

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Class IIModerate

FDAJun 14, 2018Nationwide• SCA Pharmaceuticals, LLC

Phenylephrine HCL 10mg (SCA) – Sterility Concern (2018)

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Class IIModerate

FDAJun 14, 2018Nationwide• SCA Pharmaceuticals, LLC

Diltiazem HCL Sodium Chloride (SCA) – Sterility Concern (2018)

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Class IIModerate

FDAJun 14, 2018Nationwide• SCA Pharmaceuticals, LLC

Labetalol HCl Injection (SCA) – Incorrect Labeling (2018)

Labeling; Incorrect or Missing Lot number/Expiration Date; some product labels incorrectly indicates a compounding date of 12/27/2018 and use-by date of 03/27/2019 instead of 12/27/2017 and use-by-date of 03/27/2018

Class IIILow

FDAFeb 22, 2018GA, NE, PA• SCA Pharmaceuticals, LLC.